STAT - Reporting from the frontiers of health and medicine

Sign up for our newsletter, D.C. Diagnosis, to get analysis of the most important healthcare news coming out of Capitol Hill. Sign up

First Opinion

By Su Linna

Biotech

Pharmalot

Health The herd to the rescue: How an invisible shield can keep us healthy
First Opinion Drones delivering medical supplies and more can help save American lives
Health Tufts to review ties to Purdue Pharma after ‘deeply troubling’ disclosures
Biotech This small Canadian drug maker is taking on Allergan and its best-selling eye drop medicine
Biotech Tyme Technologies misleads with new data on pancreatic cancer drug

Exclusive analysis of biotech, pharma, and the life sciences

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

After its own megamerger, Celgene signs deals with two biotechs for their cancer drugs
How sound in a video game ‘helps the medicine go down’ for kids with ADHD
Groups opposing Medicare Part D talks are criticized for failing to disclose industry ties

Health

By Kelsey McKinney

In the Lab

Special Report

In the Lab

Special Report

In the Lab

Pharmalot Drug maker payments to doctors are linked to higher opioid overdose deaths
In the Lab Macular degeneration trial will be first human test in U.S. of Nobel-winning stem cell technique
Health The herd to the rescue: How an invisible shield can keep us healthy
First Opinion Diversity in clinical trials defines good science and better medicine
Biotech This small Canadian drug maker is taking on Allergan and its best-selling eye drop medicine